• Interpace Biosciences to execute a 1-for-5 reverse stock split effective 12:01 a.m. ET on Aug. 27, 2026.
• Shares expected to trade split-adjusted on the OTCID at the market open on Aug. 27.
• Outstanding share count to drop to about 5,500,000 from about 27,700,000; authorized shares unchanged.
• Ticker to temporarily change to IDXGD for 20 trading days; new CUSIP 46062X402.
• Move aims to support a proposed Nasdaq Capital Market uplisting by addressing the minimum bid price requirement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Interpace Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608261605PRIMZONEFULLFEED9816719) on August 26, 2026, and is solely responsible for the information contained therein.